GAVI, mpox vaccine
The EU's drug regulator has approved Bavarian Nordic's mpox vaccine for use in adolescents aged 12 to 17 years, the company ...
The decision is a crucial step in getting shots to the Democratic Republic of Congo, the center of the outbreak.
“This first (authorization) of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future,” said WHO ...
The World Health Organization says it has granted its first authorization for use of a vaccine against mpox in adults, ...
The approval of Danish vaccine maker Bavarian Nordic’s jab means that donors, such as UNICEF and the vaccines alliance Gavi, ...